Products

Comprehensive catalog of pharmaceutical solutions. Browse categories and send inquiries directly.

Connect With Us

+63 919 076 9100

Targeted Therapy (Antibody-Drug Conjugate) (21)

Quick filters: Solid Tumour Hematologic Both Name A-Z Name Z-A

Therapeutic Areas

Sort by

Clear all filters

Molecule	Drug Class / Mechanism	Oncology Type	Inquiry
Datopotamab Deruxtecan	ADC	Solid Tumour
Molecule Datopotamab Deruxtecan Therapeutic Category Targeted Therapy (Antibody-Drug Conjugate) Oncology Type Solid Tumour Drug Class / Mechanism ADC
Patritumab Deruxtecan	ADC	Solid Tumour
Molecule Patritumab Deruxtecan Therapeutic Category Targeted Therapy (Antibody-Drug Conjugate) Oncology Type Solid Tumour Drug Class / Mechanism ADC
Rovalpituzumab Tesirine	ADC	Solid Tumour
Molecule Rovalpituzumab Tesirine Therapeutic Category Targeted Therapy (Antibody-Drug Conjugate) Oncology Type Solid Tumour Drug Class / Mechanism ADC
Depatuxizumab Mafodotin	ADC	Solid Tumour
Molecule Depatuxizumab Mafodotin Therapeutic Category Targeted Therapy (Antibody-Drug Conjugate) Oncology Type Solid Tumour Drug Class / Mechanism ADC
Telisotuzumab Vedotin	ADC	Solid Tumour
Molecule Telisotuzumab Vedotin Therapeutic Category Targeted Therapy (Antibody-Drug Conjugate) Oncology Type Solid Tumour Drug Class / Mechanism ADC
Zilovertamab Vedotin	ADC	Solid Tumour
Molecule Zilovertamab Vedotin Therapeutic Category Targeted Therapy (Antibody-Drug Conjugate) Oncology Type Solid Tumour Drug Class / Mechanism ADC
Ladiratuzumab Vedotin	ADC	Solid Tumour
Molecule Ladiratuzumab Vedotin Therapeutic Category Targeted Therapy (Antibody-Drug Conjugate) Oncology Type Solid Tumour Drug Class / Mechanism ADC
Cofetuzumab Pelidotin	ADC	Solid Tumour
Molecule Cofetuzumab Pelidotin Therapeutic Category Targeted Therapy (Antibody-Drug Conjugate) Oncology Type Solid Tumour Drug Class / Mechanism ADC
Farletuzumab Ecteribulin	ADC	Solid Tumour
Molecule Farletuzumab Ecteribulin Therapeutic Category Targeted Therapy (Antibody-Drug Conjugate) Oncology Type Solid Tumour Drug Class / Mechanism ADC

Datopotamab Deruxtecan Targeted Therapy (Antibody-Drug Conjugate)
Therapeutic Category Targeted Therapy (Antibody-Drug Conjugate) Oncology Type Solid Tumour Drug Class / Mechanism ADC
Patritumab Deruxtecan Targeted Therapy (Antibody-Drug Conjugate)
Therapeutic Category Targeted Therapy (Antibody-Drug Conjugate) Oncology Type Solid Tumour Drug Class / Mechanism ADC
Rovalpituzumab Tesirine Targeted Therapy (Antibody-Drug Conjugate)
Therapeutic Category Targeted Therapy (Antibody-Drug Conjugate) Oncology Type Solid Tumour Drug Class / Mechanism ADC
Depatuxizumab Mafodotin Targeted Therapy (Antibody-Drug Conjugate)
Therapeutic Category Targeted Therapy (Antibody-Drug Conjugate) Oncology Type Solid Tumour Drug Class / Mechanism ADC
Telisotuzumab Vedotin Targeted Therapy (Antibody-Drug Conjugate)
Therapeutic Category Targeted Therapy (Antibody-Drug Conjugate) Oncology Type Solid Tumour Drug Class / Mechanism ADC
Zilovertamab Vedotin Targeted Therapy (Antibody-Drug Conjugate)
Therapeutic Category Targeted Therapy (Antibody-Drug Conjugate) Oncology Type Solid Tumour Drug Class / Mechanism ADC
Ladiratuzumab Vedotin Targeted Therapy (Antibody-Drug Conjugate)
Therapeutic Category Targeted Therapy (Antibody-Drug Conjugate) Oncology Type Solid Tumour Drug Class / Mechanism ADC
Cofetuzumab Pelidotin Targeted Therapy (Antibody-Drug Conjugate)
Therapeutic Category Targeted Therapy (Antibody-Drug Conjugate) Oncology Type Solid Tumour Drug Class / Mechanism ADC
Farletuzumab Ecteribulin Targeted Therapy (Antibody-Drug Conjugate)
Therapeutic Category Targeted Therapy (Antibody-Drug Conjugate) Oncology Type Solid Tumour Drug Class / Mechanism ADC

‹ 1 2 ›